76
Participants
Start Date
March 1, 2016
Primary Completion Date
March 31, 2016
Study Completion Date
December 5, 2019
Pharmacogenomic-testing with NEUROPHARMAGEN
"This observational retrospective study aims at evaluating the impact of the genetic variation in individual genes on the therapeutic response and side effects profile in a bipolar disorder cohort, using NEUROPHARMAGEN.~NEUROPHARMAGEN is a pharmacogenomic-based decision support tool that helps clinicians in the selection and dosing of psychoactive drugs based on the integration of pharmacogenetic information."
Hospital Clínic de Barcelona, Barcelona
Hospital Clinic of Barcelona
OTHER
AB Biotics, SA
INDUSTRY